Pediatrix Medical Group (MD) to Release Earnings on Tuesday

Pediatrix Medical Group (NYSE:MD) is anticipated to release its earnings data before the market opens on Tuesday, February 18th. Analysts expect Pediatrix Medical Group to post earnings of $0.37 per share and revenue of $486.22 million for the quarter.

Pediatrix Medical Group Price Performance

Shares of MD stock opened at $13.99 on Tuesday. The firm has a fifty day moving average of $13.85 and a two-hundred day moving average of $12.61. The firm has a market cap of $1.20 billion, a P/E ratio of -4.57, a P/E/G ratio of 1.38 and a beta of 1.57. Pediatrix Medical Group has a 1-year low of $6.62 and a 1-year high of $16.41. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.42 and a quick ratio of 1.42.

Insider Buying and Selling

In other news, Director Mark S. Ordan sold 27,600 shares of the firm’s stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total transaction of $423,660.00. Following the transaction, the director now directly owns 138,683 shares of the company’s stock, valued at approximately $2,128,784.05. This trade represents a 16.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on MD shares. Macquarie assumed coverage on Pediatrix Medical Group in a report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. UBS Group raised their price objective on Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a “neutral” rating in a research note on Tuesday, November 5th. Jefferies Financial Group increased their target price on shares of Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. StockNews.com raised shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Finally, Mizuho increased their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 19th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $16.25.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.